United Therapeutics Corporation (UTHR)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,444,000 | 5,984,800 | 4,796,700 | 3,958,900 | 3,395,200 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $6,444,000K
= 0.00
The debt-to-equity ratio for United Therapeutics Corporation has remained stable at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt to finance its operations and has primarily used equity to fund its activities. A debt-to-equity ratio of 0.00 typically suggests that the company has a conservative financial structure with low financial risk, as there is no debt in relation to equity. Despite the lack of debt, it's important to consider other financial metrics to gain a full understanding of the company's financial health and performance.
Peer comparison
Dec 31, 2024